BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 15519746)

  • 1. Facilitatory effects of WAY-100635, a 5-HT1A receptor antagonist, on lordosis in female rats.
    Kishitake M; Yamanouchi K
    Neurosci Lett; 2004 Nov; 371(2-3):147-51. PubMed ID: 15519746
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Additive inhibition of lordosis by simultaneous treatments with GABA(A) and GABA(B) receptor agonists, muscimol and baclofen, in female rats.
    Wada S; Yamada S; Yamanouchi K
    Pharmacol Biochem Behav; 2008 Oct; 90(4):590-3. PubMed ID: 18539316
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence that the 5-HT1A autoreceptor is an important pharmacological target for the modulation of cocaine behavioral stimulant effects.
    Carey RJ; DePalma G; Damianopoulos E; Shanahan A; Müller CP; Huston JP
    Brain Res; 2005 Feb; 1034(1-2):162-71. PubMed ID: 15713268
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of highly or relatively selective 5-HT1A receptor agonists on lordosis in female rats.
    Kishitake M; Yamanouchi K
    Zoolog Sci; 2003 Sep; 20(9):1133-8. PubMed ID: 14578574
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Suppressive effect of neonatal treatment with a phytoestrogen, coumestrol, on lordosis and estrous cycle in female rats.
    Kouki T; Okamoto M; Wada S; Kishitake M; Yamanouchi K
    Brain Res Bull; 2005 Jan; 64(5):449-54. PubMed ID: 15607833
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antagonist-induced increase in 5-HT1A-receptor expression in adult rat hippocampus and cortex.
    Abbas SY; Nogueira MI; Azmitia EC
    Synapse; 2007 Jul; 61(7):531-9. PubMed ID: 17447257
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Attenuating effects of prior oestradiol benzoate priming on 5-HT-mediated lordosis behavior in rats are dose-dependent.
    Siddiqui A; Shaharyar S
    Acta Physiol Hung; 2007 Sep; 94(3):209-21. PubMed ID: 17853773
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of estrogen on the lordosis-inhibiting action of ketanserin and SB 206553.
    Sinclair-Worley L; Uphouse L
    Behav Brain Res; 2004 Jun; 152(1):129-35. PubMed ID: 15135976
    [TBL] [Abstract][Full Text] [Related]  

  • 9. WAY100635 and female rat lordosis behavior.
    Uphouse L; Wolf A
    Brain Res; 2004 Jul; 1013(2):260-3. PubMed ID: 15193537
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 5-HT(1A) receptors in endogenous regulation of neuropathic hypersensitivity in the rat.
    Wei H; Pertovaara A
    Eur J Pharmacol; 2006 Mar; 535(1-3):157-65. PubMed ID: 16545367
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of the 5-HT1A receptor ligands flesinoxan and WAY 100635 given systemically or microinjected into the laterodorsal tegmental nucleus on REM sleep in the rat.
    Monti JM; Jantos H
    Behav Brain Res; 2004 May; 151(1-2):159-66. PubMed ID: 15084431
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serotonin1A-receptor antagonism blocks psychostimulant properties of diethylpropion in marmosets (Callithrix penicillata).
    Mello EL; Maior RS; Carey RJ; Huston JP; Tomaz C; Müller CP
    Eur J Pharmacol; 2005 Mar; 511(1):43-52. PubMed ID: 15777778
    [TBL] [Abstract][Full Text] [Related]  

  • 13. WAY 100635 produces discriminative stimulus effects in rats mediated by dopamine D(4) receptor activation.
    Marona-Lewicka D; Nichols DE
    Behav Pharmacol; 2009 Feb; 20(1):114-8. PubMed ID: 19179855
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential effects of 5-HT2C receptor ligands on place conditioning and locomotor activity in rats.
    Mosher T; Hayes D; Greenshaw A
    Eur J Pharmacol; 2005 May; 515(1-3):107-16. PubMed ID: 15896731
    [TBL] [Abstract][Full Text] [Related]  

  • 15. WAY-100635 antagonist-induced plasticity of 5-HT receptors: regulatory differences between a stable cell line and an in vivo native system.
    Khawaja XZ; Smith DL; Nawoschik SP; Zhang J; Dunlop J; Dilks DW; Olsen M; Schechter LE
    J Neurochem; 2006 Jul; 98(1):134-45. PubMed ID: 16805803
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Facilitatory and inhibitory effects of beta-endorphin on lordosis in female rats: relation to time of administration.
    Torii M; Kubo K; Sasaki T
    Horm Behav; 1999 Jun; 35(3):271-8. PubMed ID: 10373339
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 5-HT1A and 5-HT1B receptor agonists and aggression: a pharmacological challenge of the serotonin deficiency hypothesis.
    de Boer SF; Koolhaas JM
    Eur J Pharmacol; 2005 Dec; 526(1-3):125-39. PubMed ID: 16310183
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Involvement of median raphe nucleus 5-HT1A receptors in the regulation of generalized anxiety-related defensive behaviours in rats.
    Vicente MA; Zangrossi H; dos Santos L; de Macedo CE; Andrade TG
    Neurosci Lett; 2008 Nov; 445(3):204-8. PubMed ID: 18789373
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Unilateral lesion of the nigrostriatal pathway induces an increase of neuronal firing of the midbrain raphe nuclei 5-HT neurons and a decrease of their response to 5-HT(1A) receptor stimulation in the rat.
    Wang S; Zhang QJ; Liu J; Wu ZH; Wang T; Gui ZH; Chen L; Wang Y
    Neuroscience; 2009 Mar; 159(2):850-61. PubMed ID: 19174182
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Restraint accentuates the effects of 5-HT2 receptor antagonists and a 5-HT1A receptor agonist on lordosis behavior.
    Uphouse L; White S; Harrison L; Hiegel C; Majumdar D; Guptarak J; Truitt WA
    Pharmacol Biochem Behav; 2003 Aug; 76(1):63-73. PubMed ID: 13679218
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.